
Avinger AVGR
Quarterly report 2024-Q3
added 11-07-2024
Avinger DSO Ratio 2011-2026 | AVGR
Annual DSO Ratio Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.4 | 54 | 51.8 | 61.8 | 58.3 | 53.2 | 41.4 | 67.8 | 70.2 | 67.3 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.2 | 41.4 | 57.5 |
Quarterly DSO Ratio Avinger
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50 | 57 | 58.7 | - | 43.9 | 43.2 | 50 | - | 57.4 | 56.6 | 66.7 | - | 61.5 | 54 | 53.8 | - | 58.8 | 92.4 | 59.4 | - | 55.2 | 57.4 | 64.8 | - | 52.1 | 51.2 | 57.5 | - | 49.7 | 41.8 | 61.4 | 69.6 | 61.3 | 69.6 | 56.6 | 65.8 | 69.1 | 61.7 | 90.2 | 61.4 | 71.7 | 55.7 | 44.5 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.4 | 41.8 | 59.2 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Inari Medical
NARI
|
48 | - | - | $ 4.23 B | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | ||
|
Penumbra
PEN
|
46.5 | $ 338.24 | - | $ 13.2 B | ||
|
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | ||
|
NanoVibronix
NAOV
|
29.7 | - | - | $ 1.08 M | ||
|
Natus Medical Incorporated
NTUS
|
79 | - | 1.94 % | $ 1.05 B | ||
|
Ra Medical Systems
RMED
|
2.15 K | - | 10.0 % | $ 610 K | ||
|
ShockWave Medical
SWAV
|
46.5 | - | - | $ 12.3 B | ||
|
SmileDirectClub
SDC
|
127 | - | -53.45 % | $ 9.71 M | ||
|
ReWalk Robotics Ltd.
RWLK
|
101 | - | 7.07 % | $ 66.1 M | ||
|
Sientra
SIEN
|
128 | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
42.8 | - | - | $ 1.07 B | ||
|
SeaSpine Holdings Corporation
SPNE
|
59.5 | - | 0.28 % | $ 270 M | ||
|
Surgalign Holdings
SRGA
|
78.5 | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
39.9 | - | - | $ 6.6 M | ||
|
Zynex
ZYXI
|
42.6 | - | - | $ 21.1 M | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 108.49 | - | $ 189 B | ||
|
ThermoGenesis Holdings
THMO
|
45.2 | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
30.6 | - | 3.55 % | $ 7.96 M |